BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27942860)

  • 1. Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer.
    Liang W; Xie Z; Cui W; Guo Y; Xu L; Wu J; Guan H
    J Cancer Res Clin Oncol; 2017 Apr; 143(4):601-611. PubMed ID: 27942860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-128 suppresses the growth of thyroid carcinoma by negatively regulating SPHK1.
    Cao XZ; Bin H; Zang ZN
    Biomed Pharmacother; 2019 Jan; 109():1960-1966. PubMed ID: 30551451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
    Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L
    Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.
    Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L
    Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2.
    Xue KC; Hu DD; Zhao L; Li N; Shen HY
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of key genes and miRNAs markers of papillary thyroid cancer.
    Qiu J; Zhang W; Zang C; Liu X; Liu F; Ge R; Sun Y; Xia Q
    Biol Res; 2018 Nov; 51(1):45. PubMed ID: 30414611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.
    Dettmer M; Perren A; Moch H; Komminoth P; Nikiforov YE; Nikiforova MN
    Thyroid; 2013 Nov; 23(11):1383-9. PubMed ID: 23427895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profiles of microRNAs and their target genes in papillary thyroid carcinoma.
    Liu X; He M; Hou Y; Liang B; Zhao L; Ma S; Yu Y; Liu X
    Oncol Rep; 2013 Apr; 29(4):1415-20. PubMed ID: 23380809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
    Yang Z; Yuan Z; Fan Y; Deng X; Zheng Q
    Mol Med Rep; 2013 Nov; 8(5):1353-8. PubMed ID: 24064622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
    Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
    BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
    Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X
    Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation and tumor-promoting role of SPHK1 were attenuated by miR-330-3p in gastric cancer.
    Wang Z; Qu H; Gong W; Liu A
    IUBMB Life; 2018 Nov; 70(11):1164-1176. PubMed ID: 30281914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.
    Geraldo MV; Nakaya HI; Kimura ET
    Oncotarget; 2017 Feb; 8(6):9597-9607. PubMed ID: 28030816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray profiling of circular RNAs in human papillary thyroid carcinoma.
    Peng N; Shi L; Zhang Q; Hu Y; Wang N; Ye H
    PLoS One; 2017; 12(3):e0170287. PubMed ID: 28288173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma.
    Wang Z; Zhang H; Zhang P; Dong W; He L
    Tumour Biol; 2016 Jun; 37(6):7633-44. PubMed ID: 26687649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression profiling of circulation microRNAs in PTC patients with non-131I and 131I-avid lungs metastases: a pilot study.
    Qiu ZL; Shen CT; Song HJ; Wei WJ; Luo QY
    Nucl Med Biol; 2015 May; 42(5):499-504. PubMed ID: 25682061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-506 suppresses liver cancer angiogenesis through targeting sphingosine kinase 1 (SPHK1) mRNA.
    Lu Z; Zhang W; Gao S; Jiang Q; Xiao Z; Ye L; Zhang X
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):8-13. PubMed ID: 26549227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells.
    Lima CR; Geraldo MV; Fuziwara CS; Kimura ET; Santos MF
    BMC Cancer; 2016 Feb; 16():108. PubMed ID: 26883911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
    Ma Y; Qin H; Cui Y
    Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma.
    Chou CK; Chi SY; Huang CH; Chou FF; Huang CC; Liu RT; Kang HY
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4357-4366. PubMed ID: 27533309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.